Roche is now marketing Vesanoid
January 1996
Roche is now marketing Vesanoid...in both the U.S. and Canada. It's the first vitamin A derivative to be approved for cancer.
Vesanoid is an oral form of tretinoin...the same ingredient that's in Retin-A.
Retinoids don't kill cancer cells like traditional chemo-therapy. Instead they help induce remission by getting immature cancer cells to differentiate and mature normally. These mature cells then die naturally.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive